Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muscle glycogenosis.

S W Moses1

  • 1Department of Pediatrics, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Journal of Inherited Metabolic Disease
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

This review details four genetic disorders of muscle glycogen breakdown, highlighting varied clinical, biochemical, and genetic aspects. Understanding these inborn errors is crucial for diagnosing and managing glycogen storage diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[On the article: "Psoriasis. Natural versus artificial balneophototherapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2010
Same author

Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.

Journal of inherited metabolic disease·2004
Same author

Neurophysiologic studies in congenital insensitivity to pain with anhidrosis.

Pediatric neurology·2001
Same author

Glycogen storage disease type 1a in three siblings with the G270V mutation.

Journal of inherited metabolic disease·1999
Same author

Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.

The Journal of biological chemistry·1999
Same author

Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.

American journal of human genetics·1998
Same journal

Biallelic Loss-Of-Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Muscle glycogen breakdown is essential for energy supply during physical activity.
  • Inborn errors in this pathway lead to glycogen storage diseases with diverse clinical presentations.
  • Four key enzyme deficiencies impact muscle glycogenolysis: phosphorylase, phosphorylase kinase, amylo-1,6-glucosidase, and acid alpha-glucosidase.

Purpose of the Study:

  • To review the clinical, biochemical, and genetic characteristics of four inborn errors of muscle glycogen breakdown.
  • To elucidate the heterogeneity observed in these genetic disorders.
  • To provide a comprehensive overview for researchers and clinicians.

Main Methods:

  • Literature review of clinical, biochemical, and genetic studies.

Related Experiment Videos

  • Analysis of reported data on enzyme deficiencies, residual enzyme activity, and protein expression.
  • Examination of genetic heterogeneity at mRNA and DNA levels.

    • Main Results:

    • The four disorders exhibit a wide spectrum of clinical manifestations, including variable age of onset, disease progression, and tissue involvement.
    • Biochemical variability is evident in residual enzyme levels and the presence/absence of enzyme protein.
    • Genetic heterogeneity is documented for all four deficiencies, affecting mRNA and, in some cases, DNA.

    Conclusions:

    • Significant clinical, biochemical, and genetic heterogeneity exists among these four inborn errors of muscle glycogen breakdown.
    • Understanding this variability is key to accurate diagnosis and effective management strategies.
    • Further research into specific mutations and their functional consequences can improve patient outcomes.